VAXIMM Company

VAXIMM is a vaccine company offers VXM01 targeting tumor vasculature.
Technology: DNA
Industry: DNA
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 2008-01-01
Employees Number: 1-10
Investors Number: 4
Total Funding: 32500000
Estimated Revenue: Less than $1M
Last Funding Date: 2012-10-02
Last Funding Type: Grant

Visit Website
info@vaximm.com
Register and Claim Ownership